Lactatemia as a possible pharmacological marker of NOS-inhibitor T1023 induced radioresistance

«Radiation and Risk», 2020, vol. 29, No. 1, pp.45-56

DOI: 10.21870/0131-3878-2020-29-1-45-56


Makarchuk V.M. – Senior Researcher, C. Sc., Biol.
Filimonova M.V. – Head of Lab., D. Sc., Biol. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249035. Tel.: +7 (484) 399-71-36; e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Filimonov A.S. – Researcher
Shevchenko L.I. – Lead. Researcher, C. Sc., Chem.
Izmestieva O.S. – Lead. Researcher, C. Sc., Biol.
Saburova A.S. – Researcher. A.Tsyb MRRC

A. Tsyb MRRC, Obninsk


The aim was to study the dynamics of lactatemia and acid-base balance as a possible indicator of hypoxic and radioprotective effect of the nitric oxide synthase (NOS) inhibitor T1023. The research methods included the assessment of lactate content, blood gases content and acid-base balance of arterial blood and comparison of these data with cardiovascular and radioprotective effects of compound T1023. The results show that the dynamics of lactate content and compensatory shifts in blood gases and acid-base balance, that prevent the development of acidosis, are the results of hypoxic effect of T1023 and such effects clearly correlate with cardiovascular effects that induce transient hypoxia. Comparison of these data with radiobiological effects of T1023 revealed the pronounced correlation between radioprotective effect of this compound and induced by it lactatemia. At the same time, the revealed correlation is quantitatively described by simple linear models. The obtained data show that hypoxic and radioprotective effects of NOS-inhibitor T1023 that change over time can be revealed using available laboratory methods. This suggests that lactatemia can be used as a pharmacological marker of changes in biological object’s radioresistance. Full verification of such marker could potentially allow T1023 to overcome existing obstacles in the clinical trials of radioprotectors.

Key words
NOS inhibitors, hypoxic radioprotector, lactatemia, acid-base balance, pharmacological marker.


1. Singh V.K., Seed T.M. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation subsyndromes, animal models and FDA-approved counter-measures. Int. J. Radiat. Biol., 2017, vol. 93, no. 9, pp. 851-869.

2. Proskuryakov S.Y., Kucherenko N.G., Trishkina A.I., Filimonova M.V., Shevchuk A.G., Shtein L.V., Verkhovsky Y.G., Konoplyannikov A.G., Skvortsov V.G., Mandrugin A.A., Fedoseev V.M., Skvortsov V.G. NO-inhibiting and vasotropic activity of some compounds with thioamidine group. Byulleten’ eksperimental’noy biologii i meditsiny – Bulletin of Experimental Biology and Medicine, 2002, vol. 134, no. 4, pp. 338-341. (In Russian).

3. Filimonova M.V., Shevchenko L.I., Trofimova T.P., Makarchuk V.M., Shevchuk A.S., Lushnikova G.A. On the mechanism of radioprotective effect of NO-synthase inhibitors. Radiatsionnaia biologiia. Radioecologiia – Radiation Biology. Radioecology, 2014, vol. 54, no. 5, pp. 500-506. (In Russian).

4. Filimonova M.V., Shevchenko L.I., Makarchuk V.M., Chesnakova E.A., Izmestieva O.S., Korneeva T.S., Filimonov A.S. Radioprotective properties of NO-synthase inhibitor T1023: I. Indicators of radioprotective activity and interaction with other radioprotectors. Radiatsionnaia biologiia. Radioecologiia – Radiation Biology. Radioecology, 2015, vol. 55, no. 3, pp. 250-259. (In Russian).

5. Filimonova M.V., Samsonova A.S., Korneeva T.S., Shevchenko L.I., Saburov V.O., Filimonov A.S. The radioprotective effects of nitric oxide synthase inhibitor T1023 on normal and malignant tissues. Radiatsiya i risk – Radiation and Risk, 2018, vol. 27, no. 4, pp. 155-169. (In Russian).

6. Schmidt R.F., Thews G. Human Physiology. Vol. 2. Russ. eds.: P.G. Kostuk. Moscow, GEOTAR-Media, 2004. 314 p. (In Russian).

7. Bochkov V.N., Dobrovol'skij А.B., Kushlinskij N.E., Loginov V.А., Panchenko E.P., Ratner E.I., Tvorogova M.G., Titov V.N., Tkachuk V.А. Clinical biochemistry. Moscow, GEOTAR-Media, 2004. 512 p. (In Russian).

8. Dementieva I.I. Laboratory diagnosis and clinical assessment of disorders of homeostasis in critically ill patients. Moscow, Russian Scientific Center of Surgery of RAMS, 2005. 85 p. (In Russian).

9. Sheid P. Fundamental and clinical physiology. Section 11: Acid-base equilibrium. Russ. eds.: A.G. Kamkin, A.A. Kamensky. Moscow, Akademiya, 2003, pp. 840-858. (In Russian).

10. Rozhdestvensky L.M., Fedotova M.I., Romanov A.I., Belousova O.I. Mechanisms of counteraction to radiation of pharmaceutical preparations RS-10, merkamine and mexamine. Radiatsionnaia biologiia. Radioecologiia. – Radiation Biology. Radioecology, 2017, vol. 57, no. 5, pp. 540-544. (In Russian).

11. Makarchuk V.M., Filimonova M.V., Izmestieva O.S., Chesnakova E.A., Samsonova A.S., Korneeva T.S., Shevchenko L.I., Filimonov A.S. Radioprotective properties of NO-synthase inhibitor T1023: III. Mechanisms of radioprotective action in vivo. Radiatsionnaia biologiia. Radioecologiia. – Radiation Biology. Radioecology, 2016, vol. 56, no. 6, pp. 590-597 (In Russian).

Full-text article (in Russian)